Yu-Rice, Y
Jin, Y
Han, B
Qu, Y
Johnson, J
Watanabe, T
Cheng, L
Deng, N
Tanaka, H
Gao, B
Liu, Z
Sun, Z
Bose, S
Giuliano, A E
Cui, X
Article History
Received: 11 September 2015
Revised: 5 January 2016
Accepted: 12 February 2016
First Online: 4 April 2016
Competing interests
: Xiaojiang Cui is a named inventor for patent applications regarding the role of FOXC1 in cancer. The remaining authors declare no conflict of interest.